“Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells – high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation.”

Bruserud Ø, Reikvam H, Fredly H, Skavland J, Hagen KM, van Hoang TT, Brenner AK, Kadi A, Astori A, Gjertsen BT, Pendino F.

Oncotarget. 2014 Dec 26


Categories: Article